Halo Healthcare, Inc Email Format
Biotechnology ResearchCalifornia, United States0-1 Employees
Halo Healthcare, Inc. operates in biotechnology research and is based in Irvine, California. It traces its origins to NeoMatrix LLC and underwent restructuring in 2012. The company aims to provide early, affordable, noninvasive breast cancer risk assessment and detection tests for women. It plans to operate clinical laboratories to enhance affordability and accelerate adoption of its tests. The HALO Breast Test is an FDA-cleared annual test that provides risk data to women and physicians for guiding preventive measures. It targets women who may be at higher risk due to family history, dense breasts, or hormone use. Halo Healthcare also maintains a protein-based diagnostic platform, and its AURA Breast Test is in clinical development using biomarkers licensed by the company.